227 related articles for article (PubMed ID: 26654241)
1. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.
Tsai LC; Hsieh HY; Lu KY; Wang SY; Mi FL
Nanomedicine (Lond); 2016 Jan; 11(1):9-30. PubMed ID: 26654241
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy.
Li T; Zhang M; Wang J; Wang T; Yao Y; Zhang X; Zhang C; Zhang N
AAPS J; 2016 Jan; 18(1):146-55. PubMed ID: 26381779
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Dynamic Disentangling of Doxorubicin Release from Luminescent Nanogold Carriers by Fluorescence Lifetime Imaging Microscopy (FLIM) under Two-Photon Excitation.
Suarasan S; Craciun AM; Licarete E; Focsan M; Magyari K; Astilean S
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7812-7822. PubMed ID: 30707545
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin encapsulated clicked gold nanoparticle clusters exhibiting tumor-specific disassembly for enhanced tumor localization and computerized tomographic imaging.
Mao W; Kim HS; Son YJ; Kim SR; Yoo HS
J Control Release; 2018 Jan; 269():52-62. PubMed ID: 29113793
[TBL] [Abstract][Full Text] [Related]
8. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-Incorporated Nanotherapeutic Delivery System Based on Gelatin-Coated Gold Nanoparticles: Formulation, Drug Release, and Multimodal Imaging of Cellular Internalization.
Suarasan S; Focsan M; Potara M; Soritau O; Florea A; Maniu D; Astilean S
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22900-13. PubMed ID: 27537061
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Ruan S; He Q; Gao H
Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
[TBL] [Abstract][Full Text] [Related]
11. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
12. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
[TBL] [Abstract][Full Text] [Related]
13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity.
Alle M; G BR; Kim TH; Park SH; Lee SH; Kim JC
Carbohydr Polym; 2020 Feb; 229():115511. PubMed ID: 31826400
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded fucoidan capped gold nanoparticles for drug delivery and photoacoustic imaging.
Manivasagan P; Bharathiraja S; Bui NQ; Jang B; Oh YO; Lim IG; Oh J
Int J Biol Macromol; 2016 Oct; 91():578-88. PubMed ID: 27267570
[TBL] [Abstract][Full Text] [Related]
19. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores.
Jang H; Ryoo SR; Kostarelos K; Han SW; Min DH
Biomaterials; 2013 Apr; 34(13):3503-10. PubMed ID: 23395274
[TBL] [Abstract][Full Text] [Related]
20. Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate.
Wu DC; Cammarata CR; Park HJ; Rhodes BT; Ofner CM
Pharm Res; 2013 Aug; 30(8):2087-96. PubMed ID: 23686374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
